MicroRNA therapeutics: Discovering novel targets and developing specific therapy
- PMID: 27141472
- PMCID: PMC4840794
- DOI: 10.4103/2229-3485.179431
MicroRNA therapeutics: Discovering novel targets and developing specific therapy
Abstract
MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression in diverse biological process. They act as intracellular mediators that are necessary for various biological processes. MicroRNAs targeting pathways of human disease provide a new and potential powerful candidate for therapeutic intervention against various pathological conditions. Even though, the information about miRNA biology has significantly enriched but we still do not completely understand the mechanism of miRNA gene regulation. Various groups across the globe and pharmaceutical companies are conducting research and developments to explore miRNA based therapy and build a whole new area of miroRNA therapeutics. Consequently, few miRNAs have entered the preclinical and clinical stage and soon might be available in the market for use in humans.
Keywords: Clinical stage; gene expression; microRNA; therapeutics.
Figures
Similar articles
-
Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics.RNA Biol. 2019 Jun;16(6):707-718. doi: 10.1080/15476286.2019.1593094. Epub 2019 Apr 3. RNA Biol. 2019. PMID: 30900502 Free PMC article. Review.
-
MicroRNA Key to Angiogenesis Regulation: MiRNA Biology and Therapy.Curr Cancer Drug Targets. 2018;18(3):266-277. doi: 10.2174/1568009617666170630142725. Curr Cancer Drug Targets. 2018. PMID: 28669338 Review.
-
miRNA and cancer; computational and experimental approaches.Curr Pharm Biotechnol. 2014;15(5):429. doi: 10.2174/138920101505140828161335. Curr Pharm Biotechnol. 2014. PMID: 25189575
-
MicroRNA therapeutics: the emerging anticancer strategies.Recent Pat Anticancer Drug Discov. 2014;9(3):286-96. doi: 10.2174/1574892809666140307101519. Recent Pat Anticancer Drug Discov. 2014. PMID: 24605908 Review.
-
Small non-coding RNAs as novel therapeutics.Curr Mol Med. 2010 Jun;10(4):361-8. doi: 10.2174/156652410791317048. Curr Mol Med. 2010. PMID: 20455856 Review.
Cited by
-
MiR-128-3p - a gray eminence of the human central nervous system.Mol Ther Nucleic Acids. 2024 Feb 6;35(1):102141. doi: 10.1016/j.omtn.2024.102141. eCollection 2024 Mar 12. Mol Ther Nucleic Acids. 2024. PMID: 38419943 Free PMC article. Review.
-
MiR-181a-5p knockdown ameliorates sevoflurane anesthesia-induced neuron injury via regulation of the DDX3X/Wnt/β-catenin signaling axis.Exp Brain Res. 2024 Mar;242(3):571-583. doi: 10.1007/s00221-023-06739-x. Epub 2024 Jan 13. Exp Brain Res. 2024. PMID: 38218948
-
Hepatitis B Virus and microRNAs: A Bioinformatics Approach.Int J Mol Sci. 2023 Dec 7;24(24):17224. doi: 10.3390/ijms242417224. Int J Mol Sci. 2023. PMID: 38139051 Free PMC article. Review.
-
MicroRNA as a potential biomarker for systemic lupus erythematosus: pathogenesis and targeted therapy.Clin Exp Med. 2023 Dec;23(8):4065-4077. doi: 10.1007/s10238-023-01234-7. Epub 2023 Nov 3. Clin Exp Med. 2023. PMID: 37921874 Review.
-
A Current Landscape on Alport Syndrome Cases: Characterization, Therapy and Management Perspectives.Biomedicines. 2023 Oct 12;11(10):2762. doi: 10.3390/biomedicines11102762. Biomedicines. 2023. PMID: 37893135 Free PMC article. Review.
References
-
- Czech MP. MicroRNAs as therapeutic targets. N Engl J Med. 2006;354:1194–5. - PubMed
-
- Lee RC, Feinbaum RL, Ambros V. The C.elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843–54. - PubMed
-
- Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000;403:901–6. - PubMed
-
- Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–8. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources